US Patent No. 10,350,262


Patent No. 10,350,262
Issue Date July 16, 2019
Title Mcj Agonists And Uses Therefor
Inventorship Mercedes Rincon, Burlington, VT (US)
Thomas Roberts, Denver, CO (US)
Tina Thornton, Westford, VT (US)
Assignee University of Vermont and State Agricultural College, Burlington, VT (US)

Claim of US Patent No. 10,350,262

1. A method of increasing a chemo-sensitivity of a cancer cell, the method comprising, contacting a cancer cell with one or more exogenous MCJ agonist compounds in an amount effective to increase sensitivity of the cancer cell to one or more chemotherapeutic agents, wherein the exogenous MCJ agonist compound comprises an MCJ molecule and the exogenous MCJ agonist compound further comprises one or more targeting agents.